27315-1-AP

antibody from Proteintech Group

Targeting: STAMBPL1 ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

27315-1-AP

Provider

Proteintech Group

Product name

STAMBPL1 antibody

Antibody type

Polyclonal

Description

STAMBPL1 antibody (Cat. #27315-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

A MYC-STAMBPL1-TOE1 positive feedback loop mediates EGFR stability in hepatocellular carcinoma.

Zhang H, Wang Z, Zhang J, Li Z, Liu J, Yu J, Zhao Y, Guo F, Chen WD, Wang YD
Cell reports 2024 Oct 22;43(10):114812

---

STAMBPL1, transcriptionally regulated by SREBP1, promotes malignant behaviors of hepatocellular carcinoma cells via Wnt/β-catenin signaling pathway.

Jin J, Wang Y, Hu Y
Molecular carcinogenesis 2024 Nov;63(11):2158-2173

---

A multi-omic analysis reveals that Gamabufotalin exerts anti-hepatocellular carcinoma effects by regulating amino acid metabolism through targeting STAMBPL1.

Zheng P, Xu D, Cai Y, Zhu L, Xiao Q, Peng W, Chen B
Phytomedicine : international journal of phytotherapy and phytopharmacology 2024 Dec;135:156094

---

STAMBPL1 promotes the progression of lung adenocarcinoma by inhibiting DHRS2 expression.

Yang X, Ling L, Li C, Hu T, Zhou C, Chen J, Wang Y, Hu L
Translational oncology 2023 Sep;35:101728